Literature DB >> 23217482

Fibrinoid necrosis and hyalinization observed in normal, diabetic and hypertensive placentae.

Farrah Shams1, Muhammad Rafique, Nawaz Ali Samoo, Raheel Irfan.   

Abstract

OBJECTIVE: To determine the fibrinoid necrosis and hyalinization extent in placenta observed in normal, diabetic and hypertensive pregnancies. STUDY
DESIGN: Comparative cross-sectional study. PLACE AND DURATION OF STUDY: Institute of Basic Medical Sciences, Dow University of Health Sciences, Karachi, from 2008-2010.
METHODOLOGY: One hundred and fifty placentae were divided in three groups on the basis of their histories and clinical examination. Group A (control), Group B (Diabetic) and Group C (Hypertensive), each consisted of 50 samples. The samples were transferred to Dow Diagnostic Reference and Research Laboratory for histopathology and gross examination. The tissue samples were taken from different sites, processed and routine staining done. The slides were then examined under light microscope for hyalinization and fibrinoid necrosis. The data was analyzed by applying ANOVA and post-hoc Tukey at 95% confidence interval. Mean ± standard deviations (SD) were computed.
RESULTS: The mean number of hyalinized villi in control group was 0.54 ± 0.908, 1.18 ± 1.9540 in the diabetic group and 2.14 ± 1.863 in the hypertensive group. The difference in their average turned out to be statistically significant (p-value < 0.001). Mean number of villi having fibrinoid necrosis was statistically significant in both the diabetic and hypertensive groups as compared to the control group i.e. 13.98 vs. 4.02 and 10.08 vs. 4.02 respectively (p-value < 0.001).
CONCLUSION: There was significantly greater fibrinoid necrosis and hyalinization in placentae from mothers having diabetes and hypertension. The fibrinoid necrosis was seen more in diabetic group as compared to hypertensive and control, while hyalinization was observed more frequently in hypertensive group as compared to the other groups. Placental changes as seen in examination of delivered placentae will be helpful in preventing the adverse effects in successive pregnancies.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23217482     DOI: 12.2012/JCPSP.769772

Source DB:  PubMed          Journal:  J Coll Physicians Surg Pak        ISSN: 1022-386X            Impact factor:   0.711


  4 in total

Review 1.  A systematic review of placental pathology in maternal diabetes mellitus.

Authors:  J Huynh; D Dawson; D Roberts; R Bentley-Lewis
Journal:  Placenta       Date:  2014-12-05       Impact factor: 3.481

2.  Immunohistochemical distribution of cell cycle proteins p27, p57, cyclin D3, PCNA and Ki67 in normal and diabetic human placentas.

Authors:  Gozde Unek; Aslı Ozmen; Inanc Mendilcioglu; Mehmet Simsek; Emin Turkay Korgun
Journal:  J Mol Histol       Date:  2013-08-21       Impact factor: 2.611

Review 3.  Placental structural abnormalities in gestational diabetes and when they develop: A scoping review.

Authors:  Erin Ehlers; Omonseigho O Talton; Danny J Schust; Laura C Schulz
Journal:  Placenta       Date:  2021-04-26       Impact factor: 3.287

4.  Histopathological Changes in Placenta of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Cov-2) Infection and Maternal and Perinatal Outcome in COVID-19.

Authors:  Ruchika Garg; Rachana Agarwal; Divya Yadav; Saroj Singh; Harendra Kumar; Ritu Bhardwaj
Journal:  J Obstet Gynaecol India       Date:  2022-09-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.